secwatch.observer — SEC 8-K summary
======================================

Issuer:     Jaguar Health, Inc. (JAGX)
CIK:        0001585608
Form:       8-K
Filed at:   2026-06-25T13:15:57+00:00
Accession:  0001193125-26-281969
Event type: other_material
Sentiment:  neutral
Materiality: 0.45
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Jaguar Health converts Series O Preferred Stock to common at 3.209:1, pays $2.68 for fractions
--------------------------------------------------------------------------------

- Each share of Series O Preferred Stock converted into 3.209 common shares on June 25, 2026; fractional shares paid in cash at $2.68/share.
- Preferred stock was issued as a one-time stock dividend to common stockholders and warrant holders of record March 2, 2026.
- Company targeting Breakthrough Therapy designation for crofelemer in MVID with NDA filing planned for H1 2027.
- Initial MVID patient in proof-of-concept trial showed up to 37% reduction in parenteral support needs; data presented at ESPGHAN June 2026.
- First Amendment to supply agreement with Woodward clarifies inventory title transfer and transition period through Dec 31, 2026.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1585608/000119312526281969/0001193125-26-281969-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1585608/000119312526281969/d110630d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-281969

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer